Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

Clinical trial NCT04688736 · RECRUITING

Trial details

NCT number: NCT04688736
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Transfusion Reaction

Start date: 2021-01-01
Primary completion: 2026-12-31
Enrollment: 6642

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.